Cardiol Therapeutics Class Stock Widgets and Gadgets
| CRDL Stock | USD 1.21 0.02 1.63% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CRDL Cardiol Therapeutics Class
- Latest PRISM MarketView Features QA with President and CEO David Elsle
- CRDL 1.21 -0.02
- Low 1.17
- High 1.24
- Alpha -0.64
- Beta 0.21
- Return On Equity -1.08
- Return On Asset -0.54
- Current Valuation 88.84 M
- Shares Outstanding 81.6 M
- Shares Owned By Insiders 3.91 %
- Shares Owned By Institutions 9.50 %
- Number Of Shares Shorted 1.32 M
- Price To Book 13.63 X
- Price To Sales 1,069 X
- Gross Profit 78.76 K
- EBITDA (29.59 M)
- Net Income (28.13 K)
- Cash And Equivalents 70.45 M
- Cash Per Share 1.14 X
- Total Debt 174.34 K
- Debt To Equity 0 %
- Current Ratio 6.48 X
- Book Value Per Share 0.43 X
- Cash Flow From Operations (25.18 K)
- Short Ratio 1.37 X
- Earnings Per Share (0.38) X
- Target Price 8.63
- Beta 0.7
- Market Capitalization 99.76 M
- Total Asset 36.7 M
- Retained Earnings (142.58 M)
- Working Capital 51.63 M
- Net Asset 36.7 M
- Accumulation Distribution 0.0565
- Daily Balance Of Power (0.29)
- Rate Of Daily Change 0.98
- Day Median Price 1.21
- Day Typical Price 1.21
- Market Facilitation Index 0.07
- Price Action Indicator (0.01)
- Period Momentum Indicator (0.02)
Market Snapshot Widget Example
DAX Index Germany | 20,903 1.20 | |
Taiwan Weighted Taiwan | 23,148 0.53 | |
PSI 20 Stock Portugal | 6,564 1.07 | |
CROBEX Croatia | 3,367 0.18 | |
Budapest SE Hungary | 84,879 0.94 | |
IDX 30 Jakarta Indonesia | 428.62 0.65 | |
ISEQ 20 Price Ireland | 1,632 0.91 | |
NYSE Comp USA | 19,607 0.30 | |
Tel Aviv 35 Israel | 2,525 0.41 | |
Coreshares Index Tracker South Afric | 1,119 0.18 | |
IPC MEXICO Mexico | 49,931 0.02 | |
KL Technology Malaysia | 60.74 1.13 | |
IBEX 35 Index Spain | 11,916 0.64 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,780 1.47 | |
SPASX Dividend Opportunities Australia | 1,683 0.31 | |
HNX 30 Vietnam | 462.19 1.35 | |
Bucharest BET-NG Romania | 1,229 0.12 | |
AMS Small Cap Netherlands | 1,274 0.47 | |
Oslo Exchange Mutual Norway | 1,445 0.51 | |
BEL Small Belgium | 8,518 0.44 | |
Basic Materials Brazil | 5,417 2.39 | |
Swiss Leader Price Switzerland | 1,986 0.0005 | |
Fondo Mutuo ETF Chile | 1,450 0.63 | |
Athens General Comp Greece | 1,525 1.18 | |
Stock Exchange Of Thailand | 1,341 0.88 | |
PX Prague Stock Czech Repub | 1,812 1.47 | |
THE PHILIPPINE STOCK Philippines | 6,352 1.38 | |
WIG 30 Poland | 2,948 1.30 | |
BIST Electricity Turkey | 518.27 0.19 |
Investing Ideas
In addition to having Cardiol Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Cardiol Therapeutics
Compare Cardiol Therapeutics To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. If investors know Cardiol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiol Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cardiol Therapeutics is measured differently than its book value, which is the value of Cardiol that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiol Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cardiol Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiol Therapeutics' market value can be influenced by many factors that don't directly affect Cardiol Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.